جست‌وجوی استاد و پژوهشگر

• Gastrointestinal Epidemiology
• Metabolic Dysfunction-Associated Steatotic Liver Disease
• Inflammatory Bowel Disease
• +۴ مورد دیگر

Fahim Ebrahimi is a Postdoctoral Researcher at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics, working within Jonas Ludvigsson's Gastrointestinal Epidemiology research group. His research spans multiple disciplines including hepatology, gastroenterology, endocrinology, and epidemiology, with a particular focus on metabolic dysfunction-associated steatotic liver disease (MASLD), inflammatory bowel disease, and their systemic complications. His primary research interests include: Gastrointestinal epidemiology and disease patterns MASLD/NAFLD progression and complications Inflammatory bowel disease and associated conditions Cardiovascular risks in metabolic and gastrointestinal disorders Maternal-fetal health outcomes related to liver disease Dr. Ebrahimi's recent publications (2023-2025) demonstrate a strong focus on nationwide cohort studies examining the long-term consequences of MASLD, inflammatory bowel disease, and related conditions. His work frequently employs population-based methodologies to investigate connections between gastrointestinal diseases and systemic complications including cardiovascular events, cancer risk, and mortality. His research shows particular strength in multigenerational studies examining familial patterns of disease. His scientific contributions include: Multiple publications in high-impact journals including Gastroenterology, Lancet Regional Health, and Journal of Clinical Endocrinology & Metabolism Research examining bidirectional disease associations (e.g., between microscopic colitis and primary sclerosing cholangitis) Studies on the impact of MASLD across multiple organ systems Investigations into maternal-fetal health outcomes related to liver disease Dr. Ebrahimi has secured competitive research funding from the Swiss National Science Foundation and the Swiss Academy of Medical Sciences for projects including 'Characterization of Determinants of Disease Occurrence, Progression and Adverse Clinical Outcomes in Metabolic-Associated Fatty Liver Disease' and 'Effects of IL-1 Beta on the hypothalamic-pituitary-gonadal (HPG) axis in men with obesity and metabolic syndrome.'

Elisa De Francoمشاهده پروفایل

پژوهشگر ارشد

• Genetics
• Neonatal Diabetes
• Pancreatic Development
• +۵ مورد دیگر

Dr. Elisa De Franco is a Clinical and Biomedical Sciences researcher at the University of Exeter Medical School , affiliated with the NIHR Exeter Biomedical Research Centre. She has held prestigious fellowships including the Diabetes UK RD Lawrence Fellowship (2019-2024) and the EFSD/Novo Nordisk Future Leaders Fellowship (2023-2028). Elisa leads the neonatal diabetes genetic testing service at Diabetes Genes . Education: BSc (University of Turin, Italy, 2008) MSc (University of Turin, Italy, 2010) PhD (Peninsula College of Medicine & Dentistry, 2014) Research Focus: Elisa investigates genetic causes of neonatal diabetes, pancreatic development, and beta cell dysfunction. Her work integrates exome sequencing, whole genome sequencing, and bioinformatics to uncover novel disease mechanisms, with applications in type 1 diabetes research and cell-based therapies . Scientific Contributions: Her research has identified genes like PAX4, ZNF808, and FICD in neonatal diabetes etiology. She has published extensively in journals like Journal of Clinical Investigation and Diabetologia , with a focus on genotype-phenotype correlations , endoplasmic reticulum stress , and imprinting disorders . Awards: Diabetes UK RD Lawrence Fellowship (2019) EFSD/Novo Nordisk Future Leaders Fellowship (2023) Marie Curie BOLD Project Funding (PhD) Professional Activities: Elisa works part-time as a Healthcare Scientist in the NHS Exeter exome service (2017-2019) and leads international collaborations, including studies on genetic etiologies in Sudan, Vietnam, and Kurdistan. She is a key contributor to consensus reports on precision diabetes medicine.

Kristen E. Funkمشاهده پروفایل

استادیار

• Neuroimmunology
• Viral Encephalitis
• Neuroinflammation
• +۵ مورد دیگر

Kristen E. Funk, Ph.D., serves as an Assistant Professor in the Department of Biological Sciences within the College of Arts and Sciences at the University of North Carolina at Charlotte. Her research program focuses on the intersection of neuroimmunology and neurodegenerative diseases, specifically investigating how viral encephalitis triggers neuroinflammatory processes that contribute to cognitive dysfunction and Alzheimer's disease pathology. Dr. Funk teaches undergraduate courses including BIOL 3111 (Cell Biology) and BIOL 4279/5279 (Neurobiology), bringing her research expertise into the classroom. Her laboratory employs murine models of viral infection, particularly the Kunjin strain of West Nile virus and mouse hepatitis virus, to study neuroimmune responses and their long-term cognitive consequences. 2014-2019: Postdoctoral research associate with Robyn Klein, Washington University School of Medicine, Department of Internal Medicine, Division of Infectious Diseases 2012-2014: Postdoctoral research associate with Marc Diamond, Washington University School of Medicine, Department of Neurology 2007-2012: Ph.D. in Molecular, Cellular, and Developmental Biology with Jeff Kuret, Ohio State University, Department of Molecular and Cellular Biochemistry 2004-2007: B.A. in Zoology, Miami University, Oxford, Ohio Dr. Funk's research has revealed critical connections between viral infections, neuroinflammation, and neurodegenerative processes. Her publication record demonstrates expertise spanning both neuroimmunology (particularly West Nile virus and microglial responses) and Alzheimer's disease mechanisms (focusing on tau pathology). Her work shows how acute neuroinflammatory events can accelerate CNS aging processes and contribute to Alzheimer's disease pathology. Scientific recognition includes: RF1 AG084104 (2023-2028): Investigating the interactions between viral infection, Tau pathology, and neuroinflammation Infectious Disease Society of America grant (2022-2023): Role of Apobec3 in MHC-I antigen presentation and neuronal synaptic stability in viral neuroinflammation and Alzheimer's disease Dr. Funk actively mentors students at all levels, with current Ph.D. students Britanie Blackhurst and Trevor Price investigating West Nile virus effects on neuroinflammation and tau pathology, respectively. Her lab has successfully trained numerous undergraduate and graduate students who have gone on to medical school, research positions, and industry careers. The lab maintains active collaborations with neuroscience and immunology researchers across institutions.

• Behavioral Neuroscience
• Behavioral Neuroendocrinology
• Biological Rhythms
• +۳ مورد دیگر

James Walton serves as a Research Assistant Professor in the Department of Neuroscience at West Virginia University School of Medicine and the Rockefeller Neuroscience Institute. His primary research examines circadian biology's intersection with neurological disorders, cancer progression, and immune function using rodent models with emphasis on sex differences and environmental light exposure. Education PhD from The Ohio State University Research Focus Dr. Walton investigates how circadian disruptions—particularly light-at-night exposure—impact stroke outcomes, cognitive decline, and mammary cancer progression. His work demonstrates that altered light cycles induce neuroinflammation, impair microglial function, and worsen vascular dementia in aged models. He explores therapeutic applications of circadian timing in pharmacology and stroke recovery, with significant findings on sex-specific responses to circadian challenges. Research Trends Analysis of Walton's 15 most recent publications reveals dominant themes: circadian disruption mechanisms (73%), stroke/cognitive impairment models (60%), cancer chronobiology (40%), and sex-difference analyses (87%). His work increasingly integrates neuroimmunology (53% of recent papers) and architectural lighting solutions for healthcare environments, establishing critical links between environmental light exposure and pathological outcomes. Research Support Alzheimer's Association grant: "Circadian Rhythms in Sundowning and Alzheimer's Disease" NIGMS Team Science project: "Sex Differences in Cognitive Recovery from Experimental Stroke" (collaborating with Drs. Shahrzad Latifi & Aminata Coulibaly) Collaborative Infrastructure As part of the Rockefeller Neuroscience Institute, Walton co-leads a multidisciplinary team investigating circadian-stroke interactions. His lab maintains active collaborations with the Department of Neuroscience on microglial function studies and with oncology researchers examining time-of-day effects in cancer models, utilizing shared facilities for circadian phenotyping and neuroimaging.

Kristen L. Zuloagaمشاهده پروفایل

استاد

• Neuroscience
• Alzheimer's Disease
• Neurovascular Biology
• +۷ مورد دیگر

Kristen L. Zuloaga, PhD is a Professor and Director of Graduate Studies in the Neuroscience and Experimental Therapeutics department at Albany Medical College . Her research focuses on understanding how sex, aging, and sex hormones influence vascular and metabolic contributions to dementia, with a particular emphasis on developing sex-specific therapeutic strategies to improve cognitive function. Dr. Zuloaga's work integrates neurovascular biology , endocrinology , and neuroimmunology to address sex differences in Alzheimer's disease and vascular cognitive impairment. 2017 Postdoctoral Fellowship, Neural Stem Cell Institute 2014 Postdoctoral Fellowship, Colorado State University 2011 PhD, Oregon Health & Science University Her recent publications highlight collaborations in sex-specific neuroinflammatory responses , metabolic-neurological interactions , and neuroprotective hormone therapies . Key findings demonstrate how menopause and high-fat diets synergistically impair cognition in mouse models, with distinct vascular and metabolic mechanisms. Scientific awards include major NIH grants ($4M and $8M) supporting research into age-related neurological diseases . She leads the Zuloaga Lab , which investigates the intersection of hormonal transitions , metabolic health , and cerebrovascular function in dementia pathogenesis.

Sylvie Friantمشاهده پروفایل

پژوهشگر

• Membrane Trafficking
• Lipid Signaling
• Yeast Model Organism
• +۴ مورد دیگر

Sylvie Friant is a Senior Researcher (DR2) at the CNRS , leading the "Membrane Trafficking and Lipid Signaling" team at the University of Strasbourg's Department of Molecular and Cellular Biology since 2006. Her research explores the intersection of cell biology , lipid signaling , and human disease modeling using yeast ( Saccharomyces cerevisiae ) as a eukaryotic model organism. Education 2006: Habilitation to Direct Research (HDR), University of Strasbourg 1997: PhD in Molecular and Cellular Biology, University Louis Pasteur 1994: Master in Molecular and Cellular Biology, University of Strasbourg 1992: Bachelor in Biochemistry, University of Strasbourg Her work focuses on membrane trafficking , phosphoinositide signaling , and yeast-based human disease models , particularly for ciliopathies and neuromuscular disorders . Recent studies investigate PYROXD1 mutations in limb-girdle muscular dystrophy, VPS15/PIK3R4's role in retinitis pigmentosa, and MTMR2/MTM1 interactions in myopathies. Scientific contributions include CNRS Bronze Medal (2005) CNRS ATIP Starting Grant (2005) AcademiaNet nominee (2016) She has directed multiple PhD projects (e.g., Matthieu Raess) and secured grants from AFM-Téléthon, IdEx, and national institutions. Her team moved to the Strasbourg Biomedical Research Center (CRBS) in 2025.

• Respiratory physiology
• Exercise intolerance
• Dyspnea mechanisms
• +۶ مورد دیگر

Dennis Jensen, PhD is an Associate Professor in the Department of Kinesiology and Physical Education within the Faculty of Education at McGill University and a Scientist with the Translational Research in Respiratory Diseases Program at the Research Institute of the McGill University Health Centre (RI-MUHC) . He additionally holds an appointment in the Department of Medicine, Division of Respiratory Medicine, MUHC . His research centres on understanding and alleviating activity-related breathlessness (dyspnea) and exercise intolerance in health, aging, obesity, and chronic cardiorespiratory disease—especially COPD. Research Interests Neuro-physiological mechanisms of dyspnea during exercise Cardiopulmonary exercise testing methodology and reference values Therapeutic interventions for exertional breathlessness (pharmacologic, sensorial, rehabilitative) COPD phenotyping via imaging, spirometry, and wearable sensors Sex- and age-related differences in ventilatory control and exercise tolerance Pulmonary vascular structure–function relationships and dysanapsis Dr Jensen directs the Clinical Exercise & Respiratory Physiology Laboratory (CERPL) , whose mission is to advance mechanistic understanding and evidence-based management of breathlessness in chronic pulmonary disease. The lab integrates whole-body cardiopulmonary testing, neuro-ventilatory measurements, advanced thoracic imaging, and digital health technologies to develop novel diagnostics and therapies. Recent Publications Trend Between 2024 and 2025, Dr Jensen has led or co-authored more than 30 peer-reviewed papers. These studies collectively chart a trajectory from mechanistic elucidation of dyspnea pathways (neural respiratory drive, pulmonary vascular dysfunction) to the creation of normative reference equations, deep-learning imaging tools, and pragmatic clinical interventions such as inhaled menthol and sensor-guided rehabilitation. The work spans bench-to-bedside translation and population-level epidemiology (CanCOLD, Canadian Respiratory Research Network). Scientific Awards No specific honours or awards are listed in the provided text. Supervision & Funding While explicit lists of trainees and grants are not supplied, Dr Jensen’s extensive publication record, leadership of CERPL, and involvement in large multicentre cohorts imply active graduate supervision and sustained competitive funding from national and international agencies. Laboratory & Collaborative Teams Dr Jensen heads the Clinical Exercise & Respiratory Physiology Laboratory (CERPL) at RI-MUHC. He collaborates widely with the CanCOLD Collaborative Research Group , the Canadian Respiratory Research Network , and interdisciplinary teams spanning kinesiology, respirology, radiology, biomedical engineering, and data science.

• Cystic fibrosis
• Primary ciliary dyskinesia
• Severe asthma
• +۶ مورد دیگر

Larry Lands, MD, PhD is a Professor in the Department of Pediatrics, Faculty of Medicine and Health Sciences at McGill University and a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) , Glen site. He leads the Translational Research in Respiratory Diseases Program within the Centre for Translational Biology, focusing on chronic pediatric lung diseases. Research Interests Clinical & Translational Research: Investigating cystic fibrosis, primary ciliary dyskinesia, and severe asthma in children. Novel Therapeutics: Developing inhalable nucleic acid and small-molecule therapies to control lung inflammation and repair airway damage. Exercise Physiology: Examining factors limiting exercise capacity in adolescents with obesity and other at-risk populations. Diagnostic Innovation: Pioneering oscillometry as a simple, child-friendly lung-function assessment tool for infants and children. Recent Research Trends His 2024–2025 publications reveal an intensified focus on cutting-edge CFTR modulator trials (e.g., elexacaftor-tezacaftor-ivacaftor comparisons), mucolytic microsphere therapies (CIL-05), and the first Canadian clinical practice guidelines on cystic-fibrosis-related diabetes. Additional work explores lung ultrasound for PCD/CF, post-lung-transplant weight dynamics, and spectral oscillometry in obese adolescents, underscoring a translational pipeline from bench to bedside. Scientific Awards & Honors No specific awards are listed in the provided text. Advising & Grant Activity While specific trainees and grants are not enumerated, his role as Senior Scientist and Professor implies active mentorship of graduate students, clinical fellows, and post-docs within the RI-MUHC and McGill University ecosystems. Labs & Teams He heads the Translational Research in Respiratory Diseases Program at the RI-MUHC, integrating bench scientists, clinical coordinators, and imaging specialists to advance pediatric respiratory medicine.

• Neonatology
• Perinatal health
• Global health
• +۳ مورد دیگر

Jessica Duby, MD, MPH, FRCPC, FAAP, is Assistant Professor in the Department of Pediatrics at McGill University’s Faculty of Medicine and Health Sciences and Associate Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC). She practices clinically in the Division of Neonatology, MUHC, and is affiliated with the Child Health and Human Development Program and the Centre for Outcomes Research and Evaluation at the RI-MUHC. Her scholarly focus lies in improving health-care delivery for sick and small newborns in resource-limited settings. She investigates how parent-led and lay-health-worker initiatives can complement professional care, aiming to enhance both community-based and hospital-based neonatal services for underserved populations. Recent publications demonstrate a consistent theme: rigorous evaluation of scalable interventions in low-resource environments. Studies span feasibility of family-integrated care in Uganda, decades-long home-based sepsis management in rural India, systematic assessment of parental participation across low- and middle-income countries, and cluster-randomised trials of neonatal care kits in Pakistan. Contact: Email: jessica.duby@mcgill.ca

Hongchao Guoمشاهده پروفایل

استادیار

• Stem Cell Differentiation
• Cardiovascular Disease
• Genetics
• +۳ مورد دیگر

Hongchao Guo is an Assistant Professor of Cardiothoracic Surgery and Adjunct Assistant Professor of Human Genetics at the University of Utah Health Sciences Center . He is affiliated with the Molecular Biology Program and Biological Chemistry Program , where his research focuses on cardiovascular development, stem cell differentiation, and precision medicine approaches for cardiovascular disease. Education: Ph.D. from Nankai University Postdoctoral training at the Stanford Cardiovascular Institute Research Focus: Dr. Guo's laboratory employs human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to investigate the genetic and epigenetic mechanisms underlying cardiovascular development and disease. His work integrates molecular biology , next-generation sequencing , and genome editing technologies to pioneer precision medicine strategies for cardiovascular disease (CVD) patients. Key research areas include: Heart development and regeneration : Studying embryonic heart formation and enhancing cardiac regenerative potential using 2D and 3D stem cell models. Cardiovascular disease modeling : Creating patient-specific iPSC-derived cardiovascular cells to understand genetic and environmental contributions to CVD susceptibility. Novel molecular targets : Identifying factors like lncRNA BANCR and epigenetic regulator SETD7 critical for cardiac lineage specification. Publications: His recent work spans RNA editing in vascular smooth muscle (ADAR1 studies), epigenetic regulation of CVD , and CRISPR-edited iPSC models for variant pathogenicity assessment. Notable contributions include Science Translational Medicine (2023) on SGLT2 inhibitors and Cell (2015) on provirus silencing in embryonic stem cells. Laboratory and Teams: Dr. Guo leads a dynamic research group at the University of Utah , leveraging advanced stem cell technologies and genomic tools. His lab collaborates extensively with the Stanford Cardiovascular Institute and other interdisciplinary teams to translate findings into therapeutic strategies.

Daniel Leungمشاهده پروفایل

استاد

• Mucosal Immunology
• MAIT Cells
• Cholera
• +۷ مورد دیگر

Daniel Leung is a Professor of Internal Medicine and Adjunct Professor of Microbiology and Immunology at the University of Utah . He holds a B.Sc. and M.Sc. from the University of British Columbia and an M.D. from Wake Forest University School of Medicine . His research focuses on Mucosal-Associated Invariant T (MAIT) cells in infections like cholera , sepsis , and diarrheal diseases , with emphasis on their immune regulatory roles and vaccine implications. Education: B.Sc., University of British Columbia M.Sc., University of British Columbia M.D., Wake Forest University School of Medicine Leung's work examines how MAIT cells contribute to B cell help , antibody production , and mucosal immunity . His team investigates these cells in human tonsil germinal centers and mouse models , particularly in cholera vaccine development using MAIT-activating ligands . Recent publications highlight his efforts in serosurveillance for cholera and SARS-CoV-2 , integrating statistical and machine learning approaches to estimate disease incidence from cross-sectional data. He also develops electronic clinical decision support tools (eCDST) for diarrhea management in low- and high-resource settings , aiming to reduce antibiotic misuse and improve patient outcomes. Key collaborations include the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) , GHESKIO (Haiti) , and institutions like Johns Hopkins and University of Florida . His research is funded by NIH (R01AI130378, R01AI135114, R01AI135115) and the Bill & Melinda Gates Foundation (OPP1198876).

Aik Choon Tanمشاهده پروفایل

استاد

• Translational Bioinformatics
• Cancer Systems Biology
• Cancer Data Science
• +۲ مورد دیگر

Aik Choon Tan is a Professor of Oncological Sciences at the University of Utah. His research focuses on translational bioinformatics, cancer systems biology, and precision oncology, with an emphasis on understanding treatment resistance through multi-omics data integration and tumor microenvironment analysis. B.Eng. (University of Technology Malaysia) Ph.D. (University of Glasgow) The Tan Lab develops computational methods to discover predictive biomarkers, predict drug combinations, and co-target tumor microenvironments. Current projects include integrative analysis of circulatory proteomes in prostate cancer, immune landscape modeling in colorectal and melanoma cancers, and inflammation-metabolism interactions in obesity-related tumors. Recent publications highlight his work in proteomic and epigenetic biomarkers, tumor-immune-microbiome interactions, and computational tools for personalized cancer vaccines. His lab provides seamless integration of computational methods with clinical research. Contact: aikchoon.tan@hci.utah.edu

Melodie Wellerمشاهده پروفایل

استادیار مدعو

• Virology
• Viral-mediated autoimmunity
• Sjögren’s syndrome
• +۳ مورد دیگر

Melodie Weller, Ph.D., is an Adjunct Assistant Professor of Microbiology and Immunology and Associate Professor of Dentistry at the University of Utah. She leads the Weller Lab, which investigates how viral infections impact oral health and chronic disease development. Education: Ph.D. – University of Montana Research Interests: Dr. Weller’s research centers on the intersection of virology, autoimmunity, and oral health. Her lab focuses on: Hepatitis Delta Virus (HDV): Investigating its role in Sjögren’s syndrome and its ability to trigger complete disease phenotypes in vivo. Post-COVID-19 Oral Disease: Exploring how SARS-CoV-2 infection impacts oral health and contributes to chronic conditions. Non-Hodgkin Lymphoma: Studying viral profiles associated with lymphoma development. Viral-Mediated Autoimmunity: Understanding how chronic viral infections disrupt immune regulation and contribute to autoimmune diseases. Research Trends: Her recent publications demonstrate a strong focus on HDV epidemiology, diagnostic strategies, and its clinical implications in autoimmune diseases. She has also contributed to understanding the neurological impacts of astrovirus infections and the implementation of COVID-19 surveillance in dental settings. Scientific Contributions: Identified HDV in salivary glands of Sjögren’s syndrome patients. Developed optimized sequencing strategies for HDV genome analysis. Contributed to global epidemiological tracking of HDV. Explored viral triggers of autoimmune diseases and lymphoma. Contact & Resources: Email: melodie.weller@hsc.utah.edu Faculty Page: Available on the University of Utah website. PubMed: Literature search available for full publication list.

• Thrombosis
• Inflammation
• Hematology
• +۳ مورد دیگر

Andrew S. Weyrich is an Adjunct Professor in the Department of Internal Medicine at the University of Utah , where he also serves as Vice President for Research and President of the University Research Foundation. His research investigates how platelets regulate thrombosis and inflammation through mRNA splicing and translational control, a field now recognized as "thromboinflammation." Education History: Postdoctoral Fellowship at University of Utah (Nora Eccles Harrison CVRTI) Postdoctoral Fellowship at Thomas Jefferson University PhD from Bowman Gray School of Medicine MA from Wake Forest University BS from Baldwin-Wallace College Research Interests center on platelet biology, thrombosis, inflammation, and molecular mechanisms of anucleate cell function. His group discovered signal-dependent pre-mRNA splicing in platelets, redefining understanding of non-genomic regulatory processes in blood clotting and immune responses. Recent Publications address miRNA regulation in GPVI signaling, platelet abnormalities in neurodegenerative diseases, glucose metabolism roles in thrombosis, and platelet microparticle interactions with tumors. Keywords span Hematology, Molecular Biology, and Translational Medicine. Scientific Awards include the prestigious William Dameshek Prize (ASH), H.A. and Edna Benning Presidential Endowed Chair, and John R. Hoidal Senior Investigator Award. He also serves on the NIH NHLBI Advisory Council. As a mentor, Dr. Weyrich directs training grants for medical students and postdoctoral fellows. His leadership at the University of Utah has driven research growth, safety initiatives, and programs addressing the opioid crisis, equity in research, and pandemic responses like COVID-19 surveillance testing.

• Urology
• Men's Health
• Prostate Diseases
• +۷ مورد دیگر

R. Drew Durtschi, MD serves as a Clinical Assistant Professor in the Department of Surgery (Urology division) at the University of Utah, practicing at Farmington Health Center and University of Utah Hospital. He is board-certified by the American Board of Family Medicine with clinical expertise spanning prostate health, stone disease, and men's health conditions. His educational background includes: M.D. from Drexel University College of Medicine M.S. in Biochemistry and Molecular Biology from Mayo Clinic Graduate School B.A. in Clinical Laboratory Sciences from Weber State University (minors: Music-Piano, Chemistry) Family Medicine Residency/Internship at Abington Jefferson University Hospital Genitourinary Fellowship at University of Utah Dr. Durtschi specializes in Benign Prostatic Hyperplasia, Bladder Cancer Screening, Cystoscopy, Erectile Dysfunction, Hypogonadism, Kidney Stones, Male Incontinence, Peyronie's Disease, Prostate Cancer Screening, and Vasectomy procedures. His patient-centered approach emphasizes clear communication and evidence-based treatment plans, consistently earning top patient satisfaction ratings. His research activity includes immunological studies related to rhinosinusitis, demonstrating interdisciplinary connections between urology and immunological responses in inflammatory conditions. While clinical practice dominates his current work, this publication indicates broader scientific interests in immune mechanisms. Patient feedback highlights exceptional clinical skills with a 4.9/5 rating from 474 reviews, featuring comments about his diagnostic efficiency, explanatory clarity, and compassionate care. Patients specifically note his expertise in prostate examinations and treatment planning for urinary conditions.